Hepatectomy effective for treatment of caudate lobe HCC

Caudate hepatocellular carcinoma (HCC) has a poorer prognosis than HCC originating from other lobes, due to its proximity to the portal trunk and inferior vena cava, which facilitate intrahepatic and systemic spread early in the disease. Hepatic resection is considered, in principle, to be the first choice treatment. In order to improve surgical outcome, it is necessary to evaluate the potential risk factors affecting long-term survival and to establish guidelines for the appropriate use of hepatectomy for caudate lobectomy.

A research article to be published on March 7, 2010 in the World Journal of Gastroenterology addresses this question. This research group, lead by Dr. Jia-Mei Yang and his colleagues in the Second Military Medical University, retrospectively evaluated 114 consecutive patients who underwent hepatic resection for caudate lobe HCC and evaluated the influences of common clinicopathologic variables on recurrence and long-term survival.

They found that hepatectomy was an effective treatment for caudate lobe HCC, and that subsegmental location of the tumor, the presence of liver cirrhosis and the size of the surgical margin affected long-term survival.

This study investigated an important and interesting issue. The results suggest that surgeons should pay more attention to the subsegmental location of the tumor, and that extended hepatectomy should be used when possible in order to achieve adequate intraoperative tumor margins, and so improve long-term survival after surgery.

Source: World Journal of Gastroenterology

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration